Tag: Health Care

Displaying 281 - 300 of 796 results.

Federal Trade Commission Chairman Jon Leibowitz issued the following statement regarding today’s decision by the U.S. Court of Appeals for the Second Circuit, which invited the plaintiffs in the Ciprofloxacin drug patent settlement case to seek further review by the full court of appeals because...
In a letter issued today, the staff of the Federal Trade Commission advised the University of Michigan that a proposed modification to reduce costs for its drug benefit program for employees, retirees, and their dependants is exempt from the Robinson-Patman Act, a U.S. antitrust law that prohibits...
The Federal Trade Commission has approved a proposed divestiture by Virginia-based health care company Carilion Clinic. Under a December 2009 settlement with the FTC, Carilion must divest a medical imaging center and an outpatient surgical center in Roanoke, Virginia, to FTC-approved buyers. That...
Today’s decision seems to reflect a growing understanding—first in Congress now in the courts—that brand name drug companies must not be allowed to make pay-offs to their generic competitors to keep low-cost generic drugs off the market. These deals are costing American consumers $3.5 billion a...
Following a public comment period, the Federal Trade Commission has approved a final settlement order in the matter of Danaher Corporation and MDS, Inc., and sent a letter to the one member of the public who commented on it. The final order settles charges that Danaher’s acquisition of MDS, as...
The Federal Trade Commission will continue working on behalf of Americans who are struggling to pay for their health care. According to our economic estimates, consumers would pocket about $3.5 billion a year if these unconscionable deals were stopped and they had earlier access to generic drugs....
“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz. “Ending pay-for-delay settlements will help control drug costs. We’re delighted about the President’s resolute support for this bipartisan initiative.” (JDL stmt)
The Federal Trade Commission has sent letters to 11 companies that promote various Omega-3 fatty acid supplements, telling them they should review their product packaging and labeling to make sure they do not violate federal law by making baseless claims about how the supplements benefit children’...
The Federal Trade Commission settled charges that the executive director of a Colorado physicians’ association actively tried to evade the terms of a 2008 FTC order by telling insurers that because she was not named individually in the order, she could simply negotiate on behalf of competing...
Roaring Fork Valley Physicians, IPA, Inc., a Colorado physicians’ group, settled Commission charges of price-fixing by agreeing to halt its use of allegedly anticompetitive negotiating tactics against health insurers. The Commission charged Roaring Fork Valley Physicians I.P.A., Inc...
A Colorado physicians’ group has settled Federal Trade Commission charges of price-fixing by agreeing to halt its use of allegedly anticompetitive negotiating tactics against health insurers. The FTC charged Roaring Fork Valley Physicians I.P.A., Inc., which represents about 80 percent of the...
Following a public comment period, the Federal Trade Commission has approved a final consent order regarding Pfizer Inc.’s recent acquisition of Wyeth, and responses to members of the public who provided comments. The final order settles charges that the transaction as proposed would have been...
The Commission challenged Danaher’s proposed acquisition of MDS Analytical Technologies, requiring that MDS divest its assets related to its laser microdissection business. The proposed settlement is designed to preserve competition in the North American market for laser...
The Federal Trade Commission announced today that it will require the divestiture of MDS Inc.’s assets related to its laser microdissection business as a condition of allowing Danaher Corporation and MDS Analytical Technologies (US) Inc. to proceed with their proposed merger. The proposed...
Federal Trade Commission Chairman Jon Leibowitz and key members of Congress, including Representative Chris Van Hollen, Chairman Bobby Rush, and Representative Mary Jo Kilroy, today renewed their call for legislation that would put an end to anticompetitive patent settlements, which drug...

Pages